A detailed history of Oppenheimer & Close, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Oppenheimer & Close, LLC holds 112,335 shares of PFE stock, worth $3.08 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares
112,335
Previous 137,460 18.28%
Holding current value
$3.08 Million
Previous $3.85 Million 15.5%
% of portfolio
3.21%
Previous 4.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $695,962 - $788,673
-25,125 Reduced 18.28%
112,335 $3.25 Million
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $186,924 - $219,040
-7,400 Reduced 5.11%
137,460 $3.85 Million
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $12,945 - $14,865
500 Added 0.35%
144,860 $4.02 Million
Q4 2023

Feb 08, 2024

BUY
$26.13 - $33.94 $138,097 - $179,372
5,285 Added 3.8%
144,360 $4.16 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $79,262 - $92,649
2,470 Added 1.81%
139,075 $4.61 Million
Q2 2023

Jul 24, 2023

SELL
$36.12 - $41.79 $190,207 - $220,066
-5,266 Reduced 3.71%
136,605 $5.01 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $28,360 - $36,921
-720 Reduced 0.5%
141,871 $5.79 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $68,261 - $89,107
-1,635 Reduced 1.13%
142,591 $7.31 Million
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $71,985 - $87,875
1,645 Added 1.15%
144,226 $6.31 Million
Q2 2022

Jul 15, 2022

SELL
$46.53 - $55.17 $346,415 - $410,740
-7,445 Reduced 4.96%
142,581 $7.48 Million
Q1 2022

May 05, 2022

BUY
$45.75 - $56.69 $103,852 - $128,686
2,270 Added 1.54%
150,026 $7.77 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $139,000 - $206,045
-3,364 Reduced 2.23%
147,756 $8.72 Million
Q3 2021

Oct 29, 2021

SELL
$39.25 - $50.42 $275,535 - $353,948
-7,020 Reduced 4.44%
151,120 $6.5 Million
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $5.68 Million - $6.43 Million
158,140 New
158,140 $6.19 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Oppenheimer & Close, LLC Portfolio

Follow Oppenheimer & Close, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & Close, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & Close, LLC with notifications on news.